Bioinformatics combined with clinical data to analyze clinical characteristics and prognosis in patients with HER2 low expression breast cancer

BACKGROUND: Human epidermal growth factor receptor 2 (HER2) is a landmark protein in determining the targeted treatment of breast cancer (BC). However, the latest research shows that different intensity of HER2 protein expression levels in BC leads to different clinical characteristics, treatment, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yongcheng, Ma, Yanfei, Li, Yanghong, Yu, Yanrong, Lu, Bimin, Liao, Liangyan, Li, Fujun, Wen, Zipeng, Jiang, Wenjun, Guo, Pengwei, Fang, Dalang, Lu, Guanming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10005990/
https://www.ncbi.nlm.nih.gov/pubmed/36915815
http://dx.doi.org/10.21037/gs-22-747

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10005990/
https://www.ncbi.nlm.nih.gov/pubmed/36915815
http://dx.doi.org/10.21037/gs-22-747

Ejemplares similares